Serge Belanger
Stock Analyst at Needham
(4.72)
# 726
Out of 4,966 analysts
977
Total ratings
48.9%
Success rate
13.8%
Average return
Main Sectors:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVMN Evommune | Reiterated: Buy | $28 | $10.54 | +165.78% | 2 | Sep 9, 2026 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Buy | $16 | $8.12 | +97.04% | 59 | Sep 8, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $112 | $73.77 | +51.82% | 53 | Aug 28, 2026 | |
| VRCA Verrica Pharmaceuticals | Reiterated: Hold | n/a | $4.91 | - | 49 | Aug 27, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $18 | $10.49 | +71.59% | 16 | Aug 17, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $15 | $7.83 | +91.69% | 36 | Aug 13, 2026 | |
| OMER Omeros | Reiterated: Hold | n/a | $18.28 | - | 55 | Aug 13, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $70 → $110 | $66.74 | +64.82% | 72 | Aug 12, 2026 | |
| MANE Veradermics | Reiterated: Buy | $164 | $98.97 | +65.71% | 3 | Aug 12, 2026 | |
| HRTX Heron Therapeutics | Reiterated: Hold | n/a | $0.3155 | - | 62 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $12.51 | +139.81% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $23.78 | -15.90% | 45 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $21.27 | +125.67% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $10.56 | +259.85% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $16.14 | +42.50% | 52 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 | $58.65 | +32.99% | 40 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $23.89 | +67.47% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $46 | $22.75 | +102.20% | 168 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.84 | - | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $21.24 | +60.08% | 36 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $33 | $25.22 | +30.87% | 81 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9517 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.98 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.78 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0077 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.0501 | n/a | 3 | Aug 19, 2016 |
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $28
Current: $10.54
Upside: +165.78%
BioCryst Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $16
Current: $8.12
Upside: +97.04%
Cytokinetics
Aug 28, 2026
Reiterated: Buy
Price Target: $112
Current: $73.77
Upside: +51.82%
Verrica Pharmaceuticals
Aug 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.91
Upside: -
Ocular Therapeutix
Aug 17, 2026
Reiterated: Buy
Price Target: $18
Current: $10.49
Upside: +71.59%
CorMedix
Aug 13, 2026
Reiterated: Buy
Price Target: $15
Current: $7.83
Upside: +91.69%
Omeros
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $18.28
Upside: -
Liquidia
Aug 12, 2026
Reiterated: Buy
Price Target: $70 → $110
Current: $66.74
Upside: +64.82%
Veradermics
Aug 12, 2026
Reiterated: Buy
Price Target: $164
Current: $98.97
Upside: +65.71%
Heron Therapeutics
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3155
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $12.51
Upside: +139.81%
Aug 7, 2026
Reiterated: Hold
Price Target: $20
Current: $23.78
Upside: -15.90%
Aug 7, 2026
Reiterated: Buy
Price Target: $48
Current: $21.27
Upside: +125.67%
Aug 7, 2026
Reiterated: Buy
Price Target: $38
Current: $10.56
Upside: +259.85%
Aug 7, 2026
Reiterated: Buy
Price Target: $23
Current: $16.14
Upside: +42.50%
Aug 7, 2026
Reiterated: Buy
Price Target: $78
Current: $58.65
Upside: +32.99%
Aug 6, 2026
Rated: Buy
Price Target: $36 → $40
Current: $23.89
Upside: +67.47%
Aug 6, 2026
Reiterated: Buy
Price Target: $56 → $46
Current: $22.75
Upside: +102.20%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.84
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $34
Current: $21.24
Upside: +60.08%
Aug 5, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $25.22
Upside: +30.87%
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.9517
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $1.98
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $22
Current: $1.78
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.0077
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.0501
Upside: n/a